A pharmacovigilance study to quantify the strength of association between the combination of antimalarial drugs and azithromycin and cardiac arrhythmias: implications for the treatment of COVID-19.
Conclusion: Hydroxychloroquine/chloroquine and/or azithromycin use was associated with safety signals for QTp/TdP and their use should be monitored carefully.
PMID: 33186061 [PubMed - as supplied by publisher]
Source: Expert Review of Pharmacoeconomics and Outcomes Research - Category: Health Management Tags: Expert Rev Pharmacoecon Outcomes Res Source Type: research
More News: Arrhythmia | Azithromycin | Cardiac Arrhythmia | COVID-19 | Electrocardiogram | Health Management | Hydroxychloroquine | Statistics | Study | Zithromax